- Home
- TSHA vs GDEN Comparison
TSHA vs GDEN Comparison
Compare TSHA & GDEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TSHA
- GDEN
- Stock Information
- Founded
- TSHA 2019
- GDEN 1998
- Country
- TSHA United States
- GDEN United States
- Employees
- TSHA N/A
- GDEN N/A
- Industry
- TSHA Biotechnology: Pharmaceutical Preparations
- GDEN Services-Misc. Amusement & Recreation
- Sector
- TSHA Health Care
- GDEN Consumer Discretionary
- Exchange
- TSHA Nasdaq
- GDEN Nasdaq
- Market Cap
- TSHA 728.4M
- GDEN 725.6M
- IPO Year
- TSHA 2020
- GDEN 1999
- Fundamental
- Price
- TSHA $2.46
- GDEN $28.98
- Analyst Decision
- TSHA Strong Buy
- GDEN Buy
- Analyst Count
- TSHA 7
- GDEN 6
- Target Price
- TSHA $7.57
- GDEN $37.00
- AVG Volume (30 Days)
- TSHA 5.2M
- GDEN 211.2K
- Earning Date
- TSHA 08-11-2025
- GDEN 08-07-2025
- Dividend Yield
- TSHA N/A
- GDEN 3.45%
- EPS Growth
- TSHA N/A
- GDEN N/A
- EPS
- TSHA N/A
- GDEN 0.39
- Revenue
- TSHA $7,224,000.00
- GDEN $653,614,000.00
- Revenue This Year
- TSHA N/A
- GDEN $1.48
- Revenue Next Year
- TSHA N/A
- GDEN $2.88
- P/E Ratio
- TSHA N/A
- GDEN $74.60
- Revenue Growth
- TSHA N/A
- GDEN N/A
- 52 Week Low
- TSHA $1.05
- GDEN $22.66
- 52 Week High
- TSHA $3.31
- GDEN $35.49
- Technical
- Relative Strength Index (RSI)
- TSHA 45.90
- GDEN 59.86
- Support Level
- TSHA $2.48
- GDEN $26.81
- Resistance Level
- TSHA $2.66
- GDEN $28.15
- Average True Range (ATR)
- TSHA 0.21
- GDEN 0.80
- MACD
- TSHA -0.06
- GDEN 0.09
- Stochastic Oscillator
- TSHA 10.14
- GDEN 88.97
About TSHA Taysha Gene Therapies Inc.
Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disease. It is focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the CNS in both rare and large patient populations. The company develops and commercializes transformative gene therapy treatments. Its product pipeline includes, TSHA-102 which is a is a self-complementary intrathecally delivered AAV9 gene transfer therapy in clinical evaluation for Rett syndrome.
About GDEN Golden Entertainment Inc.
Golden Entertainment Inc is a U.S. based company that focuses on distributed gaming, casino, and resort operations. Its reportable segments are Nevada Casino Resorts, Nevada Locals Casinos, Nevada Taverns, and Distributed Gaming. The majority of the revenue for the company is generated from its Nevada Casino Resorts segment which is comprised of destination casino resort properties offering a variety of food and beverage outlets, entertainment venues, and other amenities.